NSN 6505-01-718-5243 · NIIN 017185243 · FSC 6505
NO DASHES 6505017185243
In Stock
TRANEXAMIC ACID TABLETS
Drugs and Biologicals
Technical characteristics
6 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CSGS | ADMINISTRATION | ORAL |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | TABLETS 30.0 |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS TRANEXAMIC ACID ACTIVE INGREDIENT 650.0 |
| FEAT | SPECIAL FEATURES | TRANEXAMIC ACID USP 650MG TABLETS, 30 PER BOTTLE. ANTIFIBRINOLYTIC AGENT INDICATED FOR THE TREATMENT OF CYCLIC HEAVY MENSTRUAL BLEEDING IN FEMALES OFREPRODUCTIVE POTENTIAL. STORE AT ROOM TEMPERATURE 25 C (77 F); EXCURSIONS PERMITTED TO 15-30 C (59-86 F). (SEE USP CONTROLLED ROOM TEMPERATURE). |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | TRANEXAMIC ACID TABLETS 650MG 30'S |